Kisspeptin Peptide: How Its Story Began
What makes up the Kisspeptin peptide?
Scientists seeking a way to slow cancer spread first found the kisspeptin peptide, a small protein messenger. Later work found the gene, which holds the body's instructions for making it.
The gene first makes a 145-amino-acid protein, meaning a protein built from many small pieces. Your body cuts it into four forms: KP-54 with 54 amino acids, plus KP-14, KP-13, and KP-10. All four share one end, which fits certain brain cells like a key in a lock. KP-10 is the shortest form that still makes the full fit [1][4].
Labs record the KP-54 weight as 6142 daltons, their unit for weighing very small things. You only need to know that this form is larger and common in human blood and brain tissue. Its size makes it about 8-fold harder for blood proteins to cut. That may explain why half is gone in about 32 minutes, compared with about 4 minutes for KP-10 [12].
All four forms carry the same kind of message. For you, the useful difference is time, since the larger form stays longer.
What job does the Kisspeptin peptide have?
Kisspeptin starts the brain's sex-hormone chain. It reaches brain cells that send the first hormone message, which helps guide puberty, fertility, and monthly periods.
A cell helper called Gq/11 carries the message inward and raises calcium; its lab name matters less than its job. The cell's electrical charge shifts about 6 millivolts, a tiny electrical change, and stays raised about 21 minutes. This shows that the cell became more active. The pituitary, a hormone gland below the brain, then sends two more hormones. The ovaries or testicles can make testosterone, estrogen, and progesterone [4].
The same protein slowed the spread of some solid tumors in cancer studies [17][19]. That work doesn't show a cancer treatment for you.
Who found Kisspeptin, and what did they want to learn?
The first team studied melanoma, a skin cancer, at the Milton S. Hershey Medical Center. In 1996, they made melanoma cells produce kisspeptin. Cancer spread fell by more than 95% in special lab mice bred without working immune systems, though the first tumor still grew. This was mouse work, not a study in people [17].
The 1996 label KiSS-1 was a nod to Hershey, Pennsylvania, where the team worked and chocolate is famous. In 2001, another team found the spot where kisspeptin fits a cell. They called the protein metastin because it had slowed cancer spread.
The puberty finding came in 2003. Two groups tied rare inherited changes to puberty that didn't begin. Mice whose matching cell spot couldn't work also failed to mature [1], so both groups found the same broad result.
The work showed that the cell spot must work for puberty to begin normally, but it didn't show how to treat you.
What do the Kisspeptin gene instructions make?
Genes hold instructions that your body follows. The kisspeptin gene tells the body to make a 145-amino-acid protein, which the body later cuts into kisspeptin forms. Research lists call the gene number 3814, but you don't need that filing number to understand its job.
Researchers first described the gene in melanoma work from Hershey, Pennsylvania, in 1996 [17]. A 2003 report tied an inherited change to puberty [1]. In 2012, another study tied a gene change to puberty that hadn't begun; that report also appeared in 2012 [3].
One group of brain cells helps set hormone pulses, while another helps make the strong monthly rise needed for egg release [15].
The gene is also active in the thyroid, breast, pancreas, and liver. It slowed spread in many cancer studies, but the result changed by tissue [19].
For you, this gene links the cancer work with the hormone work. It isn't a gene treatment.
Why did early Kisspeptin papers say metastin?
The early name metastin meant the 54-amino-acid protein made from the kisspeptin gene. Researchers saw that KP-54 fit certain cells and slowed the spread of melanoma cells.
Later studies found the same 54-amino-acid protein is the body's main long form of kisspeptin. KP-54 also starts the sex-hormone chain.
Newer papers use KP-54, while older papers may say metastin. The two names point to one substance.
What can Kisspeptin Research do for you?
Kisspeptin Research reads published studies and explains their results and weak points. It isn't a clinic, drug shop, or peptide supplier, and we don't provide or plan treatment.
The name kisspeptinresearch.com tells you the site's subject, not an offer of medical care. We don't run or fund the studies, and we don't earn money from them.
You can check the papers on the full reference list. You can use the number beside each claim to find its paper. Use the contact page if a link breaks or our words don't match the paper.
Kisspeptin is still being studied. These pages aren't medical advice, and they don't suggest giving the compound to yourself.